Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation
Article first published online: 13 JUL 2012
© 2012 John Wiley & Sons A/S
European Journal of Haematology
Volume 89, Issue 3, pages 228–235, September 2012
How to Cite
Bleeker, J. S., Gertz, M. A., Pellikka, P. A., Larson, D. R., Buadi, F., Dingli, D., Dispenzieri, A., Hayman, S. R., Hogan, W., Kumar, S., Rajkumar, S. V. and Lacy, M. Q. (2012), Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation. European Journal of Haematology, 89: 228–235. doi: 10.1111/j.1600-0609.2012.01815.x
- Issue published online: 10 AUG 2012
- Article first published online: 13 JUL 2012
- Accepted manuscript online: 1 JUN 2012 12:55PM EST
- Manuscript Accepted: 28 MAY 2012
- Celgene and Travel
- Celgene, Millenium, Neotope Eisai, Inc.
- Celegene, Genzyme, Millenium, Novartis, Bayer, Merck, Cephalon, and Advisory Board
- Physician's Education Resource, and Amgen, Inc
- Lilly Research Laboratories
- Optum Health Education
- Research to Practice
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.